SEC Filing Timeline
8-KAug 12, 2026
Earnings release · Items 2.02,9.01
10-QAug 12, 2026
Quarterly report
8-KJul 31, 2026
Material agreement · Items 1.01,8.01,9.01
424B5Jul 30, 2026
Prospectus / offering
8-KJul 29, 2026
Earnings release · Items 2.02
424B5Jul 29, 2026
Prospectus / offering
S-3Jul 02, 2026
Shelf registration
8-KMay 20, 2026
Charter/bylaws amendment · Items 5.03,5.07,9.01
8-KMay 13, 2026
Earnings release · Items 2.02,9.01
10-QMay 13, 2026
Quarterly report
DEF 14AApr 07, 2026
Proxy statement
8-KApr 06, 2026
Material agreement · Items 1.01,8.01,9.01
424B5Apr 02, 2026
Prospectus / offering
8-KApr 02, 2026
Other material event · Items 8.01
424B5Apr 02, 2026
Prospectus / offering
Recent News (Finnhub)
Precigen Gains 43% in 3 Months: Is It an Indication to Buy the Stock?
Inovio Nears FDA Decision on INO-3107 as Oct. 30 PDUFA Date Looms
Inovio Pharmaceuticals, Inc. (INO) Presents at H.C. Wainwright 28th Annual Global Investment Conference Prepared Remarks Transc…
Can Papzimeos Drive Precigen's Growth Through the Rest of 2026?
Inovio Pharmaceuticals Nears Oct. 30 FDA Decision for INO-3107 in RRP
Inovio Pharmaceuticals, Inc. (INO) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript